Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04215536 · ClinicalTrials.gov registry record

Replication of the EMPAREG Diabetes Trial in Healthcare Claims

A clinical trial of Diabetes, sponsored by Brigham and Women's Hospital.

Completed
Registry status
103,752
Enrollment target
1
Study location

NCT04215536 is a study of Diabetes that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 103,752 participants, above the 2,721-participant average among 338 other Diabetes trials with a reported enrollment target (3713% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04215536, a study of Diabetes, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
103,752 participants
Enrollment target
1
Study location

Study Summary

Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.

Conditions Studied

Diabetes

Interventions

  • DRUG Empagliflozin
  • DRUG DPP-4 inhibitor

Study Locations (1)

Massachusetts

  • Brigham & Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 103,752 participants
Start Date 2019-07-08
Est. Completion 2021-02-18

Sponsor

Brigham and Women's Hospital

937 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04215536

The ClinicalTrials.gov registry entry for NCT04215536 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 103,752 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,721-participant average among 338 other Diabetes trials with a reported enrollment target (3713% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Empagliflozin is the first listed.

NCT04215536 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04215536 about?

NCT04215536 is a clinical study titled "Replication of the EMPAREG Diabetes Trial in Healthcare Claims". Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such...

What is the current status of trial NCT04215536?

This trial is currently completed. The enrollment target is 103,752 participants. The study started on 2019-07-08. Estimated completion is 2021-02-18.

What conditions does trial NCT04215536 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT04215536?

The interventions under investigation include: Empagliflozin (DRUG), DPP-4 inhibitor (DRUG).

Who is sponsoring clinical trial NCT04215536?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04215536 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.